MARKET WIRE NEWS

AngioDynamics, Inc. (ANGO) Q4 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-07-15 12:40:56 ET

AngioDynamics, Inc. (ANGO)

Q4 2025 Earnings Conference Call

July 15 2025, 08:00 AM ET

Company Participants

James C. Clemmer - CEO, President & Director

Stephen A. Trowbridge - Executive VP & CFO

Conference Call Participants

John Edward Young - Canaccord Genuity Corp., Research Division

Steven Michael Lichtman - Oppenheimer & Co. Inc., Research Division

Yi Chen - H.C. Wainwright & Co, LLC, Research Division

Presentation

Operator

Good morning and welcome to the AngioDynamics Fiscal Year 2025 Fourth Quarter Earnings Call. [Operator Instructions] As a reminder, this conference call is being recorded....

Read the full article on Seeking Alpha

For further details see:

AngioDynamics, Inc. (ANGO) Q4 2025 Earnings Call Transcript
AngioDynamics Inc.

NASDAQ: ANGO

ANGO Trading

-0.05% G/L:

$10.945 Last:

84,906 Volume:

$11 Open:

mwn-link-x Ad 300

ANGO Latest News

ANGO Stock Data

$455,039,941
38,744,343
2.99%
58
N/A
Medical Equipment & Supplies
Healthcare
US
Latham

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App